Risdiplam

Risdiplam (brand name Evrysdi) is a daily, at-home oral medication used to treat Spinal Muscular Atrophy (SMA) in adults and children (including infants from birth) by increasing the production of functional survival motor neuron (SMN) protein. It works by modifying the splicing of the SMN2 gene to treat the underlying cause of muscle